DOI · e01.org

The Prognostic Value of Pretreatment Plasma Fibrinogen in Urological Cancers: A Systematic Review and Meta-analysis

Haifeng Song, Guanyu Kuang, Zhenan Zhang, Binglei Ma, Jie Jin, Qian Zhang · Journal of Cancer · 2019

  • DOI 10.7150/jca.26989
  • Publisher Ivyspring International Publisher
  • Type review
  • Issued 2019

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Journal of Cancer · Ivyspring International Publisher · review · 2019

Abstract

Objective: Growing evidence suggests pretreatment fibrinogen can serve as a prognostic marker in various malignancies.However, there are contradictory results about the prognostic role of fibrinogen in urological cancers.We conducted a meta-analysis to evaluate the association between pretreatment plasma fibrinogen and survival outcomes in urological cancers.Methods: After a systematic search of PubMed and Embase, we included 14 studies in our meta-analysis, and estimated hazard ratios (HRs) for overall survival (OS) and cancer-specific survival (CSS) using a fixed-effect model.Results: Our results indicate that pretreatment plasma fibrinogen is a prognostic factor in urological cancers (OS: HR=2.21, 95% CI=1.91-2.57,P<0.001, CSS: HR=2.67, 95% CI=2.23-3.19,P<0.001).Elevated pretreatment plasma fibrinogen is associated with poorer survival in prostate cancer (OS: HR=2.26, 95% CI=1.47-3.48,P<0.001; CSS: HR=2.42, 95% CI=1.44-4.07,P=0.001), renal cell carcinoma (OS: HR=2.13, 95% CI=1.75-2.61,P<0.001; CSS: HR=2.99, 95% CI=2.29-3.89,P<0.001) and upper tract urothelial carcinoma (OS: HR=2.34, 95% CI=1.81-3.02,P<0.001; CSS: HR=2.43, 95% CI=1.84-3.20,P<0.001).Subgroup analyses showed that plasma fibrinogen has a more negative impact on survival in Caucasian patients (OS: HR=2.52, 95% CI=1.95-3.25,P<0.001; CSS: HR=2.83, 95% CI=1.92-4.17,P<0.001) than Asian patients (OS: HR=2.07, 95% CI=1.73-2.49,P<0.001; CSS: HR=2.63, 95% CI=2.14-3.22,P<0.001).The prognostic value of fibrinogen is also consistent when stratified by different cut-off values.Conclusions: These results show that high pretreatment plasma fibrinogen levels can predict poorer OS and CSS in patients with urological cancers.

Open the resolved locator · 10.7150/jca.26989

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-19 20:13 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://www.jcancer.org/v10p0479.htm
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.